Stannous fluoride

Generic Name
Stannous fluoride
Brand Names
Doctor's Choice, Gelato Perio Rinse, Gingi Med, Kid's Choice, PerioMed, Prodenrx Rinse
Drug Type
Small Molecule
Chemical Formula
F2Sn
CAS Number
7783-47-3
Unique Ingredient Identifier
3FTR44B32Q
Background

Stannous Fluoride, or Tn(II) Fluoride, is a compound commonly used in toothpastes for the prevention of gingivitis, dental infections, cavities, and to relieve dental hypersensitivity. Although similar in function and activity to Sodium Fluoride (NaF), the conventionally added ingredient in toothpastes, stannous fluoride has been shown to be more effective at stopping and reversing dental lesions . It manages and prevents dental caries and gingivitis by promoting enamel mineralization , reducing gingival inflammation and bleeding through its potential broad-spectrum antibiotic effect and modulation of the microbial composition of the dental biofilm . It is an FDA-approved over-the-counter product.

Indication

Indicated for use to relieve dental hypersensitivity, increase enamel production, prevent gingivitis and cavities, and control periodontal infections.

Associated Conditions
Dental Cavity
Associated Therapies
-

Stannous Fluoride and Gingivitis

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2022-04-13
Last Posted Date
2022-06-16
Lead Sponsor
Procter and Gamble
Target Recruit Count
40
Registration Number
NCT05326373
Locations
🇺🇸

Salus Research, Fort Wayne, Indiana, United States

A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride

First Posted Date
2019-10-11
Last Posted Date
2020-01-31
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
98
Registration Number
NCT04123665
Locations
🇺🇸

GSK Investigational Site, Fort Wayne, Indiana, United States

Analysis of Stannous Fluoride in GCF and Subgingival Plaque

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2017-09-28
Last Posted Date
2017-11-06
Lead Sponsor
Procter and Gamble
Target Recruit Count
20
Registration Number
NCT03296657
Locations
🇺🇸

Salus Research, Fort Wayne, Indiana, United States

The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity

First Posted Date
2017-03-07
Last Posted Date
2018-03-06
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
120
Registration Number
NCT03072719
Locations
🇮🇪

GSK Investigational Site, Cork, Ireland

A Study to Evaluate Sampling Methods for Subgingival Plaque

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-07-22
Last Posted Date
2023-11-15
Lead Sponsor
Procter and Gamble
Target Recruit Count
20
Registration Number
NCT02841839

Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

First Posted Date
2016-07-14
Last Posted Date
2017-05-25
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
242
Registration Number
NCT02832375
Locations
🇺🇸

GSK Investigational Site, Las Vegas, Nevada, United States

Impact of Long Term Management of Dentine Hypersensitivity (DH) With a Daily Use Anti-sensitivity Toothpaste on the Quality of Life Related to Oral Health

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-04-27
Last Posted Date
2018-08-27
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
75
Registration Number
NCT02752958
Locations
🇬🇧

GSK Investigational Site, Widnes, Cheshire, United Kingdom

Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-04-26
Last Posted Date
2017-10-26
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
253
Registration Number
NCT02750943
Locations
🇺🇸

GSK Investigational Site, Las Vegas, Nevada, United States

Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity

First Posted Date
2013-04-09
Last Posted Date
2015-01-26
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
119
Registration Number
NCT01827670
Locations
🇺🇸

Salus Research, Inc., Fort Wayne, Indiana, United States

The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity

First Posted Date
2012-05-07
Last Posted Date
2014-03-10
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
120
Registration Number
NCT01592864
Locations
🇺🇸

BioSci Research America, Inc., Las Vegas, Nevada, United States

© Copyright 2024. All Rights Reserved by MedPath